Why is Natco Pharma falling/rising?

As of 22-Jul, Natco Pharma Ltd. is experiencing a slight increase in its stock price, currently at 1,016.90, reflecting a change of 2.2 (0.22%) upwards. The stock has shown a positive performance today, outperforming its sector by 1.13%, and reached an intraday high of Rs 1,038.05, which is a 2.3% increase. Over the past week, Natco Pharma has gained 0.59%, while its performance over the last month is significantly stronger at +16.18%. Despite a year-to-date decline of -26.68%, the company has demonstrated healthy long-term growth, with operating profits increasing at an annual rate of 32.35%. The stock's attractive valuation, indicated by a low PEG ratio of 0.3 and a high return on equity (ROE) of 24.8, suggests that it is trading at a discount compared to its peers, which may contribute to the recent upward movement.
In the broader market context, Natco Pharma's short-term performance contrasts with the Sensex, which has declined by -0.47% over the past week. This indicates that the stock is gaining traction while the overall market is struggling. However, it is important to note that there has been a decline in investor participation, with delivery volume falling by 46.32% against the five-day average, which could signal caution among investors. Despite this, the high institutional holdings at 21.33% suggest that more knowledgeable investors are backing the stock, potentially providing a stabilizing effect amidst the fluctuations. Overall, while Natco Pharma is currently rising, the mixed signals from investor participation and broader market trends warrant careful observation.